____ didn't confirm the Spark study. We know that ICS ___ could be as effective as ___ in preventing or exacerbation different type
The dean ____ didn't confirm the Spark study. We know that ICS Lab could be as effective as ___ in preventing or exacerbation different type
The DNA titer didn't confirm the Sparks study - and we know that ICS/LABA could be as effective as tio [tiotropium] in preventing exacerbation of a different type.
The DYNAGITO [study] didn’t confirmed the SPARK study and we know that ICS/LABA
could be as effective as a TO ***** in preventing exacerbation [of] different types.
So, why should we wait to step up at this level
before going into the most effective treatment,
knowing that these three treatments are more or less as effective?